USFDA warning poses challenges for Cadila
Brokerages have cut earnings estimates for Cadila Healthcare over the next two years by five to 15 per cent following the two US Food and Drug Administration (USFDA) warning letters …
Read MoreTag: usfda
News Around the Globe